Department of - Instituut voor Tropische Geneeskunde
Department of - Instituut voor Tropische Geneeskunde
Department of - Instituut voor Tropische Geneeskunde
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Projects<br />
For more details, see www.itg.be/projects and fill in the<br />
project reference number<br />
Unit <strong>of</strong> Virology<br />
Reference number 84210/84211<br />
EMPRO European Microbicide Project<br />
ITM Promoter: G. Vanham<br />
ITM Collaborator: A. Buvé<br />
EMPRO-coordinater: C. Kelly (King’s College London)<br />
Support: European Commission<br />
Reference number 85101<br />
MMP Development <strong>of</strong> an association <strong>of</strong> one or more<br />
vaginal microbicidal formulations at the pre-clinical<br />
stage.<br />
ITM Promoter: G. Vanham<br />
MMP-coordinater: L. Belec (INSERM, France)<br />
External promoters: G. Van den Mooter, J. Balzarini & D.<br />
Schol (KUL, Belgium), S. di Fabio (ISS, Italy)<br />
Support: ANRS French National Agency for Research on<br />
Aids/Agence nationale de recherches sur le sida<br />
Reference number 100107<br />
Research collaboration on microbicides<br />
ITM promoter: G. Vanham<br />
External promoters: J. Van Roey (Tibotec, Belgium), IPM<br />
(International Partnership <strong>of</strong> Microbiocides Inc.)<br />
Support: Tibotec Pharmaceuticals Ltd, Ireland.<br />
Reference number 424402<br />
Sexual Transmission <strong>of</strong> HIV: viral selection, fitness<br />
and adaptation<br />
ITM promoter: G. Vanham<br />
ITM collaborator: J. Michiels<br />
External promoters: M. Temmerman & M. Praet<br />
(University <strong>of</strong> Ghent)<br />
Support: Research Foundation Flanders (FWO)<br />
Reference number 414401<br />
Inhibition <strong>of</strong> human immunodeficiency virus (HIV)<br />
replication<br />
ITM promoter: G. Vanham<br />
ITM collaborators: E. Van Gulck, D. Atkinson<br />
External promoters: Z. Bernemann (Antwerp University,<br />
Belgium, coordinator), B. Verhasselt (Ghent University,<br />
Belgium), M. Moutschen (University <strong>of</strong> Liège, Belgium),<br />
A-M Vandamme (Catholic University Leuven, Belgium), B.<br />
Berkhout (University <strong>of</strong> Amsterdam, The Netherlands).<br />
Support: Belgian Federal Science Policy Office (BELSPO)<br />
Reference number 100094<br />
Induction <strong>of</strong> immunity by dendritic cells in cancer and<br />
aids<br />
ITM-promoter: G. Vanham<br />
ITM-collaborators: K. Vereecken, S. Coppens, Y. Gali<br />
External promoters: Z. Berneman, E. Van Gulck and G. Van<br />
den Bosch (University <strong>of</strong> Antwerp, Belgium)<br />
Support: University <strong>of</strong> Antwerp (GOA)<br />
Reference number 100183<br />
Enhancement <strong>of</strong> antiviral immunity in seropositive<br />
individuals through vaccination with autologous<br />
dendritic cells expressing viral RNA obtained from<br />
endogenous quasispecies: preclinical evaluation in<br />
macaques<br />
ITM-promoter: G. Vanham<br />
Support: French National Agency for Research on Aids<br />
(AWRS)<br />
Reference number 424403<br />
A phase I/II study <strong>of</strong> therapeutic vaccination with<br />
autologous dendritic cells <strong>of</strong> HIV infected individuals<br />
under stable HAART<br />
ITM-promoter: G. Vanham<br />
External promoters: K. Thielemans (Free University <strong>of</strong><br />
Brussels, Belgium), Z. Berneman (Antwerp University<br />
Hospital, Belgium)<br />
Support: Institute for the Promotion <strong>of</strong> Innovation by<br />
Science and Technology in Flanders (IWT)<br />
Reference number 100217<br />
Vaccine induced protective cross-neutralisation <strong>of</strong><br />
HIV-1<br />
ITM promoters: G. Vanham, W. Janssens<br />
ITM collaborators: S. Balla-Jhagjhoorsingh, B. Willems, L.<br />
Heyndrickx, K. Vereecken, N. Loots<br />
External promoters: R.A. Weiss (University College<br />
London, United Kingdom), A. McKnight(Queen Mary<br />
University <strong>of</strong> London, United Kingdom), J. Heeney and<br />
D. Davis (Biomedical Primate Research Centre, The<br />
Netherlands), A. Lanzavecchia (Institute for Research<br />
in Biomedicine, Switzerland), Q. Sattentau (University<br />
RESEARCH | 41